跳至主要内容
临床试验/NCT03835286
NCT03835286撤回3 期

Vitamin C to Reduce Exogenous Vasopressor Dose in Septic Shock; a Randomized Clinical Trial

Hospital Español de Mexico1 个研究点 分布在 1 个国家开始时间: 2019年3月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
撤回
发起方
试验地点
1
主要终点
Vasopressor dose

研究概览

简要总结

Randomized, controlled, double blind clinical trial. Adult patients admitted to the ICU of the Hospital Español de México with a diagnosis of septic shock will be included.

Patients will be randomized to one of the study groups:

Intervention Group: Vitamin C 6 grams in 250 ml of 0.9% saline solution every 24 hours, in continuous infusion for 72 hours.

Placebo Group: 0.9% saline solution 250 ml every 24 hours, in continuous infusion for 72 hours.

详细描述

Randomized, controlled, double blind clinical trial. Adult patients admitted to the ICU of the Hospital Español de México with a diagnosis of septic shock will be included.

Patients will be randomized to one of the study groups:

Intervention Group: Vitamin C 6 grams in 250 ml of 0.9% saline solution every 24 hours, in continuous infusion for 72 hours.

Placebo Group: 0.9% saline solution 250 ml every 24 hours, in continuous infusion for 72 hours.

Bottles will be identical, only identified by the sequential number of the patient that has been included.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Septic Shock

排除标准

  • Previous treatment exceeded 24 hours
  • Refusal to participate
  • Do Not Resuscitate
  • Participation in another trial

研究组 & 干预措施

Vitamin C

Experimental

Vitamin C experimental group

干预措施: Vitamin C (Drug)

Control

Placebo Comparator

Placebos Controlled group

干预措施: Placebos (Drug)

结局指标

主要结局

Vasopressor dose

时间窗: 72 hours

Hourly dose of exogenous vasopressor

次要结局

  • Hours of vasopressor use(through study completion, an average of 30 days)
  • Days of mechanical ventilation(through study completion, an average of 30 days)
  • Days of Intensive Care Unit stay(through study completion, an average of 30 days)
  • Mortality in Intensive Care Unit(through study completion, an average of 30 days)

研究者

发起方
Hospital Español de Mexico
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jose J Zaragoza, MD

Clinical Professor

Hospital Español de Mexico

研究点 (1)

Loading locations...

相似试验